Back to results
US 11,306,115 B2Granted
Aminoglycoside derivatives and uses thereof in treating genetic disorders
AssigneeEloxx Pharmaceuticals Ltd.
InventorTimor Baasov
Life of this patent
Estimating the term…
Abstract
Novel pseudo-disaccharide and pseudo-trisaccharide aminoglycosides, represented by Formulae I or Ia, as defined in the instant specification, designed to exhibit stop codon mutation readthrough activity, are provided. Also provided are pharmaceutical compositions containing the same, and uses thereof in the treatment of genetic diseases and disorders, such as diseases and disorders associated with stop codon mutations.
Claims23
A compound represented by general formula I:
- or a pharmaceutically acceptable salt thereof,
- wherein:
- the dashed lines indicates a stereo-configuration of position 6′ being an R configuration or an S configuration;
- R1 is alkyl, cycloalkyl or aryl;
- R2 is selected from a substituted or unsubstituted alkyl, OR′ and NR′R″, wherein each of R′ and R″ is independently selected from hydrogen, a substituted or unsubstituted alkyl, a substituted or unsubstituted cycloalkyl, a substituted or unsubstituted aryl, a substituted or unsubstituted heteroaryl, a substituted or unsubstituted alkaryl, and an acyl;
- R4 is selected from an unsubstituted linear or branched alkyl, a substituted or unsubstituted cycloalkyl, a substituted or unsubstituted aryl, a substituted or unsubstituted alkaryl, a guanidinyl, and a guanyl;
- and
- R3 is hydrogen or a monosaccharide moiety represented by Formula II:
- wherein the curved line denotes a position of attachment;
- and
- R5 and R6 are each independently selected from hydrogen, a substituted or unsubstituted alkyl, a substituted or unsubstituted cycloalkyl, a substituted or unsubstituted aryl, a substituted or unsubstituted alkaryl, and a substituted or unsubstituted heteroaryl, acyl, guanidinyl, and guanyl, or, alternatively, R5 and R6 form together a heterocyclic ring.
8 more elements
Dependencies are inferred from the claim text.